Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
BioBlast®
Biosimilars Deals 2023
Biosimilars Deals 2024
Chris Vindurampulle
Diversity
Intranet
Masterclasses
Other Podcasts
Other Updates
Our Awards
Patent Case Summaries
Patent Litigation
Patents
Paul Johns
PipCast®
PTE
Trade Marks
Webinars

Alexion and Amgen announce eculizumab settlement

May 29, 2020

In a filing to the Securities and Exchange Commission, Alexion announced it has settled its US patent eculizumab dispute with Amgen.

As part of the settlement, Amgen will terminate its three US inter partes review proceedings challenging Allexion’s eculizumab patents, and receive a non-exclusive, royalty-free license to supply eculizumab in the US from 01 March 2025.

.